Harnessing Patients’ Own Immune Cells to Fight Their Cancer
The chemotherapy and radiation treatments given to cancer patients to shrink their tumors don’t always work and often have severe side effects. Sri Krishna, a postdoctoral researcher in the Intramural Research Program at the National Institutes of Health, is investigating an alternative treatment strategy that uses infection-fighting immune cells from patients’ own bodies to seek out and destroy their cancers. The approach, called adoptive cell therapy, has already seen success as a treatment for skin cancer, but his work will help expand its use to other forms of the disease, which could ultimately save many lives.
Click here to learn more about the research being done in Sri’s lab.
Interested in finding out for yourself what it’s like to do research at NIH? Check out our training opportunities to learn about the IRP’s programs for students, recent graduates, and postdoctoral fellows.
This page was last updated on Friday, May 13, 2022